Bulletin
Investor Alert

Leidos Holdings Inc.

NYS: LDOS

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Mar 5, 2021, 7:35 p.m.

/zigman2/quotes/202902477/composite

$

90.50

Change

-0.22 -0.24%

Volume

Volume 93,073

Quotes are delayed by 20 min

/zigman2/quotes/202902477/composite

Previous close

$ 89.08

$ 90.72

Change

+1.64 +1.84%

Day low

Day high

$88.85

$91.26

Open

52 week low

52 week high

$68.00

$113.75

Open

Insider Actions for Leidos Holdings Inc.

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
03/02/2021 Roger A. Krone
CEO; Director
299   Award at $0 per share. 0
03/02/2021 James Corbett Reagan
EVP, Chief Financial Officer
70   Award at $0 per share. 0
03/02/2021 James R. Moos
Group President
11   Award at $0 per share. 0
03/02/2021 Jerald S. Howe
Executive VP & General Counsel
43   Award at $0 per share. 0
03/02/2021 James Corbett Reagan
EVP, Chief Financial Officer
70   Derivative/Non-derivative trans. at $92.44 per share. 6,470
03/02/2021 Gerry Fasano
Group President
364   Derivative/Non-derivative trans. at $92.44 per share. 33,648
03/02/2021 James R. Moos
Group President
9   Derivative/Non-derivative trans. at $92.44 per share. 831
03/02/2021 Christopher R. Cage
SVP and Corporate Controller
61   Derivative/Non-derivative trans. at $92.44 per share. 5,638
03/02/2021 Schmanske Mary Vicki
Group President
75   Derivative/Non-derivative trans. at $92.44 per share. 6,933
03/02/2021 Stevens Roy E
Chief of Business Development
69   Derivative/Non-derivative trans. at $92.44 per share. 6,378
03/02/2021 Jerald S. Howe
Executive VP & General Counsel
47   Derivative/Non-derivative trans. at $92.44 per share. 4,344
03/02/2021 Paul O. Engola
Executive Vice President
71   Derivative/Non-derivative trans. at $92.44 per share. 6,563
03/02/2021 Elizabeth Porter
Group President
70   Derivative/Non-derivative trans. at $92.44 per share. 6,470
03/02/2021 Gary Stephen May
Director
500   Disposition at $91.84 per share. 45,920
02/26/2021 David G. Fubini
Director
11,685   Derivative/Non-derivative trans. at $28.84 per share. 336,995
02/18/2021 Roger A. Krone
CEO; Director
11,853   Award at $0 per share. 0
02/18/2021 Roger A. Krone
CEO; Director
70,393   Award at $0 per share. 0
02/18/2021 James Corbett Reagan
EVP, Chief Financial Officer
15,461   Award at $0 per share. 0
02/18/2021 James Corbett Reagan
EVP, Chief Financial Officer
2,531   Award at $0 per share. 0
02/18/2021 Gerry Fasano
Group President
9,540   Award at $0 per share. 0
02/18/2021 James R. Moos
Group President
2,455   Award at $0 per share. 0
02/18/2021 James R. Moos
Group President
1,912   Award at $0 per share. 0
02/18/2021 Christopher R. Cage
SVP and Corporate Controller
2,435   Award at $0 per share. 0
02/18/2021 Schmanske Mary Vicki
Group President
4,918   Award at $0 per share. 0
02/18/2021 Stevens Roy E
Chief of Business Development
1,821   Award at $0 per share. 0
02/18/2021 Stevens Roy E
Chief of Business Development
1,883   Award at $0 per share. 0
02/18/2021 Jerald S. Howe
Executive VP & General Counsel
2,978   Award at $0 per share. 0
02/18/2021 Jerald S. Howe
Executive VP & General Counsel
7,767   Award at $0 per share. 0
02/18/2021 Paul O. Engola
Executive Vice President
4,094   Award at $0 per share. 0
02/18/2021 Elizabeth Porter
Group President
3,740   Award at $0 per share. 0
02/18/2021 David A. King
Group President
1,604   Award at $0 per share. 0
02/18/2021 Roger A. Krone
CEO; Director
26,623   Derivative/Non-derivative trans. at $105.48 per share. 2,808,194
02/18/2021 James Corbett Reagan
EVP, Chief Financial Officer
537   Derivative/Non-derivative trans. at $105.48 per share. 56,642
02/18/2021 Gerry Fasano
Group President
1,858   Derivative/Non-derivative trans. at $105.48 per share. 195,981
02/18/2021 James R. Moos
Group President
619   Derivative/Non-derivative trans. at $105.48 per share. 65,292
02/18/2021 Christopher R. Cage
SVP and Corporate Controller
509   Derivative/Non-derivative trans. at $105.48 per share. 53,689
02/18/2021 Schmanske Mary Vicki
Group President
611   Derivative/Non-derivative trans. at $105.48 per share. 64,448
02/18/2021 Stevens Roy E
Chief of Business Development
118   Derivative/Non-derivative trans. at $105.48 per share. 12,446
02/18/2021 Jerald S. Howe
Executive VP & General Counsel
2,619   Derivative/Non-derivative trans. at $105.48 per share. 276,252
02/18/2021 Paul O. Engola
Executive Vice President
584   Derivative/Non-derivative trans. at $105.48 per share. 61,600
02/18/2021 Elizabeth Porter
Group President
576   Derivative/Non-derivative trans. at $105.48 per share. 60,756
01/29/2021 James Corbett Reagan
EVP, Chief Financial Officer
1,453   Derivative/Non-derivative trans. at $106.06 per share. 154,105
01/07/2021 Miriam E. John
Director
337   Award at $103.99 per share. 35,044
12/31/2020 Roger A. Krone
CEO; Director
367   Award at $0 per share. 0
12/31/2020 Harry M. Jansen Kraemer
Director
377   Award at $0 per share. 0
12/31/2020 James Corbett Reagan
EVP, Chief Financial Officer
251   Award at $0 per share. 0
12/31/2020 Miriam E. John
Director
231   Award at $0 per share. 0
12/31/2020 James R. Moos
Group President
7   Award at $0 per share. 0
12/31/2020 Christopher R. Cage
SVP and Corporate Controller
72   Award at $0 per share. 0
12/31/2020 Jerald S. Howe
Executive VP & General Counsel
16   Award at $0 per share. 0
12/31/2020 Frank Kendall
Director
16   Award at $0 per share. 0
12/01/2020 Noel Brown Williams
Director
11,685   Derivative/Non-derivative trans. at $28.84 per share. 336,995
11/23/2020 Christopher R. Cage
SVP and Corporate Controller
1,660   Derivative/Non-derivative trans. at $100.37 per share. 166,614
11/23/2020 Christopher R. Cage
SVP and Corporate Controller
3,382   Derivative/Non-derivative trans. at $27.23 per share. 92,091
11/17/2020 David G. Fubini
Director
1,411   Disposition at $99.59 per share. 140,521
11/17/2020 David G. Fubini
Director
5,500   Disposition at $98.41 per share. 541,255
11/13/2020 Roger A. Krone
CEO; Director
828   Derivative/Non-derivative trans. at $94.16 per share. 77,964
11/13/2020 Roger A. Krone
CEO; Director
1,256   Derivative/Non-derivative trans. at $94.16 per share. 118,264
11/13/2020 David G. Fubini
Director
3,233   Derivative/Non-derivative trans. at $94.16 per share. 304,419
11/13/2020 David G. Fubini
Director
10,144   Derivative/Non-derivative trans. at $30 per share. 304,320

Transaction Summary

Total insider purchases and sales reported to the SEC

Timeframe Transactions Shares
Last 3 months
30 Purchases
21 Sales
159,167
37,443
Last 6 months
44 Purchases
31 Sales
206,281
63,490
Last 12 months
88 Purchases
54 Sales
379,633
206,357

Officers and Executives

Mr. Roger A. Krone
Chairman & Chief Executive Officer
Mr. James Corbett Reagan
Chief Financial Officer & Executive VP
Mr. James F. Carlini
Chief Technology Officer
Mr. Peter ODonoghue
Chief Technology Officer
Dr. Donald Kosiak
Chief Medical Officer
Mr. Steve Hull
Chief Information Officer & Senior Vice President
Ms. Sharon G. Watts
Chief Administrative Officer
Mr. Michael Jackman
Chief Operating Officer-Health Group
Mr. James R. Moos
President-Civil Group
Mr. Roy Stevens
EVP, Chief Business Development & Strategy
Ms. Michele M. Brown
Chief Ethics & Compliance Officer, Senior VP
Mr. Gerry Fasano
Executive Vice President & President-Defense Group
Mr. Randy E. Phillips
Senior Vice President-Corporate Development
Dr. James Cantor
Chief of Performance Excellence & Strategic
Mr. Kamal Dua
Chief Audit Executive
Mr. Christopher R. Cage
Chief Accounting Officer & Controller
Mr. Peter Berl
Investor Relations Contact
Mr. Paul O. Engola
Chief Human Resources Officer & Senior VP
Mr. Benjamin A. Winter
Secretary & Senior Vice President
Mr. Jerald S. Howe
Executive Vice President & General Counsel
Mr. Rob Thomas
VP-Strategic Accounts & Government Relations
Ms. Melissa Duenas
Senior Vice President-Communications
Mr. David G. Fubini
Independent Director
Mr. Robert S. Shapard
Lead Independent Director
Ms. Noel Brown Williams
Independent Director
Dr. Gary Stephen May
Independent Director
Mr. Harry M. Jansen Kraemer
Independent Director
Mr. Gregory R. Dahlberg
Independent Director
Dr. Surya Narayan Mohapatra
Independent Director
Ms. Susan M. Stalnecker
Independent Director
Dr. Miriam E. John
Independent Director
Mr. Frank Kendall
Independent Director
Mr. Robert C. Kovarik
Independent Director
Link to MarketWatch's Slice.